(Q43457825)

23 November 2017

title

The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure (English)

1 reference

23 November 2017

2

Nadia Aspromonte

1 reference

23 November 2017

Roberto Valle

1

1 reference

23 November 2017

Sabrina Barro

3

1 reference

23 November 2017

Cristina Canali

4

1 reference

23 November 2017

Emanuele Carbonieri

5

1 reference

23 November 2017

Vincenzo Ceci

6

1 reference

23 November 2017

Maura Chinellato

7

1 reference

23 November 2017

Giovanni Gallo

8

1 reference

23 November 2017

Prospero Giovinazzo

9

1 reference

23 November 2017

Roberto Ricci

10

1 reference

23 November 2017

Loredano Milani

11

1 reference

23 November 2017

publication date

1 June 2005

1 reference

European Journal of Heart Failure

23 November 2017

published in

1 reference

23 November 2017

volume

7

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

542-551

1 reference

Guidelines for the diagnosis and treatment of chronic heart failure

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Mortality of the institutionalized old-old hospitalized with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Comprehensive multidisciplinary programs for the management of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

A systematic review of randomized trials of disease management programs in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Prevention and management of chronic heart failure in management of asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Evidence of inadequate investigation and treatment of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Open access echocardiography in management of heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Plasma brain natriuretic peptide in assessment of acute dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Natriuretic peptides in the pathophysiology of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Difficulties of introducing the National Service Framework for heart failure into general practice in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Biochemical detection of left-ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Epidemiology, aetiology, and prognosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

Heart failure associated with preserved systolic function: a common and costly clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.07.005

10.1016/J.EJHEART.2004.07.005

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference